Objective: The aim was to determine the frequency of infection in patients with immune thrombocytopenic purpura (ITP) and to detect the effect of its eradication therapy on platelet count response in -positive patients. Patients and methods:
stool antigen enzyme immunoassay test was done for 54 patients with ITP. -positive patients received standard triple therapy for 2 weeks. Platelet count response to eradication therapy was evaluated 2 and 3 months after the treatment. Results:
infection was positive in 38 (70.4%) patients with ITP. Eradication of was achieved in 30 (78.9%) patients (responder group). There were statistically significant increases in platelet count (among the responder group) after eradication therapy at 2 and 3 months ( < 0.05). Conclusion: Eradication of infection in patients with ITP is associated with significant increase in platelet counts.
Faiek, N., Hussein, S., & Badr, R. (2020). eradication therapy in patients with immune thrombocytopenic purpura. Journal of Current Medical Research and Practice, 5(1), 32-35. doi: 10.4103/JCMRP.JCMRP_154_19
MLA
Nabila Faiek; Safinaz Hussein; Reham Badr. "eradication therapy in patients with immune thrombocytopenic purpura", Journal of Current Medical Research and Practice, 5, 1, 2020, 32-35. doi: 10.4103/JCMRP.JCMRP_154_19
HARVARD
Faiek, N., Hussein, S., Badr, R. (2020). 'eradication therapy in patients with immune thrombocytopenic purpura', Journal of Current Medical Research and Practice, 5(1), pp. 32-35. doi: 10.4103/JCMRP.JCMRP_154_19
VANCOUVER
Faiek, N., Hussein, S., Badr, R. eradication therapy in patients with immune thrombocytopenic purpura. Journal of Current Medical Research and Practice, 2020; 5(1): 32-35. doi: 10.4103/JCMRP.JCMRP_154_19
)
View on SCiNiTO